COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

ASAP-TOO

Purpose of Study

Establish the safety and effectiveness of the WATCHMAN Left Atrial Appendage Closure Device for subjects with non-valvular atrial fibrillation who are deemed not to be eligible for oral anticoagulation therapy to reduce the risk of stroke

Trial Status

Enrolling

Eligibility Criteria

Subject has documented paroxysmal, persistent, permanent, or longstanding persistent non-valvular afib, deemed by two study physicians to be unsuitable for oral anticoagulation

Duration of Participation

Approximately 5 years

Contact Name: Jennifer Young, RN

Contact Phone: 515-633-3841

Contact Email: jyoung@iowaheart.com